Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its
November 14, 2025
Convenience store owner Yesway raises $280 million in US IPO
US blocks Iraq's dollar shipments to squeeze Iran-backed militias, WSJ reports
Indefinite ceasefire, markets unbothered
Asian shares are mixed and oil prices little changed as investors watch for US-Iran talks
A specialized tour at the Berlin Zoo brings joy to people living with dementia
Mexico to beef up security at tourist sites after shooting at pyramids in lead up to World Cup
Kings interim coach D.J. Smith hit by shattered glass as panel breaks behind LA bench in Game 2